MacGill, Randall S.

GITR ligand fusion protein agonist enhances the tumor antigen-specific CD8 T-cell response and leads to long-lasting memory

Durham, N. M., Holoweckyj, N., MacGill, R. S., McGlinchey, K., Leow, C. C., & Robbins, S. H. (2017) · Journal for ImmunoTherapy of Cancer

Immunotherapy and Immune ResponsesT-cell and B-cell Immunology

Cited by 48

Analysis of the Diverse Antigenic Landscape of the Malaria Invasion Protein RH5 Identifies a Potent Vaccine-Induced Human Public Antibody Clonotype

Barrett, J. R., Pipini, D., Wright, N. D., Cooper, A. J. R., Gorini, G., Quinkert, D., Lias, A. M., Davies, H., Rigby, C., Aleshnick, M., et al. (2023) · Cell

Malaria Research and ControlMonoclonal and Polyclonal Antibodies Research

Cited by 31

Preclinical Development of a Stabilized RH5 Virus-Like Particle Vaccine that Induces Improved Anti-Malarial Antibodies

King, L. D. W., Pulido, D., Barrett, J. R., Davies, H., Quinkert, D., Lias, A. M., Silk, S. E., Pattinson, D. J., Diouf, A., Williams, B. G., et al. (2024) · Cell Reports Medicine

Malaria Research and ControlImmunotherapy and Immune Responses

Cited by 27

Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies

King, L. D. W., Pulido, D., Barrett, J. R., Davies, H., Quinkert, D., Lias, A. M., Silk, S. E., Pattinson, D. J., Diouf, A., Williams, B. G., et al. (2024) · Cell Reports Medicine

Malaria Research and ControlImmunotherapy and Immune Responses

Cited by 27